One Year Efficacy and Safety Results of a Phase II Trial of Secukinumab in Patients with Rheumatoid Arthritis.

被引：0

作者：

Genovese, Mark C. ^{[1
]}

Durez, Patrick ^{[2
]}

Richards, Hanno B. ^{[3
]}

Supronik, Jerzy ^{[4
]}

Dokoupilova, Eva ^{[5
]}

Aelion, Jacob A. ^{[6
]}

Lee, Sang-Heon ^{[7
]}

Codding, Christine E. ^{[8
]}

Kellner, Herbert ^{[9
]}

Ikawa, Takashi ^{[10
]}

Hugot, Sophie ^{[3
]}

Ligozio, Gregory ^{[11
]}

Mpofu, Shephard ^{[3
]}

机构：

[1] Stanford Univ, Palo Alto, CA 94304 USA

[2] Catholic Univ Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium

[3] Novartis Pharma AG, Basel, Switzerland

[4] NZOZ Ctr Med Artur Racewicz, Bialystok, Poland

[5] Med Plus Sro, Uherske Hradiste, Czech Republic

[6] Arthrit Clin, Jackson, TN USA

[7] Konkuk Univ Med Ctr, Seoul, South Korea

[8] Hlth Res Oklahoma, Oklahoma City, OK USA

[9] Ctr Inflammatory Joint Dis, Munich, Germany

[10] Kobe Konan Yamate Clin, Kobe, Hyogo, Japan

[11] Novartis Pharmaceut, E Hanover, NJ USA

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

401

引用

页码：S149 / S150

页数：2

共 50 条

[1] One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
Genovese, Mark C.
Durez, Patrick
Richards, Hanno B.
Supronik, Jerzy
Dokoupilova, Eva
Aelion, Jacob A.
Lee, Sang-Heon
Codding, Christine E.
Kellner, Herbert
Ikawa, Takashi
Hugot, Sophie
Ligozio, Gregory
Mpofu, Shephard
JOURNAL OF RHEUMATOLOGY, 2014, 41 (03) : 414 - 421
[2] Efficacy and Safety of Subcutaneous and Intravenous Loading Dose Regimens of Secukinumab in Patients with Active Rheumatoid Arthritis: Results from a Randomized Phase II Study
Tlustochowicz, Witold
Rahman, Proton
Seriolo, Bruno
Krammer, Gerhard
Porter, Brian
Widmer, Albert
Richards, Hanno B.
JOURNAL OF RHEUMATOLOGY, 2016, 43 (03) : 495 - 503
[3] Efficacy and Safety of Iguratimod for Rheumatoid Arthritis.
Kondo, Tsuneo
Shibata, Akiko
Sakai, Ryota
Chino, Kentaro
Okuyama, Ayumi
Takei, Hirofumi
Amrano, Koichi
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S659 - S659
[4] Efficacy and Safety of 22-Oxa-Calcitriol in Patients with Rheumatoid Arthritis: A Phase II Trial
Li, Chaohong
Yin, Songlou
Yin, Hanqiu
Cao, Lina
Zhang, Ting
Wang, Yong
MEDICAL SCIENCE MONITOR, 2018, 24 : 9127 - 9135
[5] Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial
Genovese, Mark C.
Pacheco-Tena, Cesar
Covarrubias, Arturo
Leon, Gustavo
Mysler, Eduardo
Keiserman, Mauro
Valente, Robert M.
Nash, Peter
Abraham Simon-Campos, J.
Box, Jane
Legerton, Clarence W., III
Nasonov, Evgeny
Durez, Patrick
Elegbe, Ayanbola
Wong, Robert
Li, Xiaohui
Banerjee, Subhashis
Alten, Rieke
JOURNAL OF RHEUMATOLOGY, 2018, 45 (08) : 1085 - 1092
[6] Efficacy and safety of tofacitinib in older and younger patients with rheumatoid arthritis.
Curtis, J. R.
Schulze-Koops, H.
Takiya, L.
Mebus, C.
Terri, K.
Biswas, P.
Jones, T.
PHARMACOTHERAPY, 2014, 34 (10): : E225 - E225
[7] Efficacy and Safety of Adalimumab Therapy in Japanese Patients with Rheumatoid Arthritis.
Hattori, Yosuke
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S219 - S220
[8] RESULTS OF A ONE-YEAR TRIAL OF TOLMETIN IN PATIENTS WITH RHEUMATOID-ARTHRITIS
BROWN, JH
HULL, J
BIUNDO, JJ
JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 15 (5-6): : 455 - 463
[9] Results of the extension phase of the open trial of thaldomide in the treatment of rheumatoid arthritis.
Scoville, CD
ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1523 - 1523
[10] Phase II trial of epitope-specific immunotherapy in rheumatoid arthritis.
Albani, S
Tremoulet, A
Genovese, M
Schiff, M
Dennehey, C
Posever, J
Belardi, F
Santana, E
Molitor, J
Bathon, J
Matteson, E
Kavanaugh, A
Martinez, A
Amox, D
Keogh, E
Berry, C
Cutter, G
Puga-Yung, G
Gosch, C
Koffeman, E
Friend, S
Zieseniss, P
Samodal, R
Le, T
ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4059 - 4059

← 1 2 3 4 5 →